Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 281 - 300 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »
Reset 

GeneDx Holdings Announces Pricing Of A $150 Million Underwritten Public Offering Of Class A Common Stock And Concurrent Registered Direct Offering

Read more ››
By: GlobenewsWire - 27 Jan 2023

Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results

Read more ››
By: PR Newswire Association LLC. - 27 Jan 2023
Related companies:  Samsung Biologics Co., Ltd.

IO360º Summit Honors Women Leaders in Immuno-Oncology R&D

Read more ››
By: PR Newswire Association LLC. - 27 Jan 2023

Laboratory Balances and Scales Market to Reach $1.6 Billion, Globally, by 2031 at 4.4% CAGR: Allied Market Research

Read more ››
By: PR Newswire Association LLC. - 27 Jan 2023

Invitation: Sobi's Q4 and FY 2022 report

Read more ››
By: PR Newswire Association LLC. - 27 Jan 2023
Related companies:  Swedish Orphan Biovitrum AB (Sobi™) | Swedish Orphan Biovitrum AG

Rakovina Therapeutics Announces Presentation at the 6th Annual DDR-inhibitors Summit

Read more ››
By: GlobenewsWire - 27 Jan 2023
Related companies:  Rakovina Therapeutics

Dupixent® (dupilumab) Recommended for Expanded EU Approval by the CHMP to Treat Children as Young as Six Months Old with Severe Atopic Dermatitis

Read more ››
By: GlobenewsWire - 27 Jan 2023
Related companies:  Regeneron Pharmaceuticals Inc.

argenx Receives Notification of PDUFA Date Extension for SC Efgartigimod

Read more ››
By: GlobenewsWire - 27 Jan 2023
Related companies:  argenx SE

Press Release: Dupixent® (dupilumab) recommended for expanded EU approval by the CHMP to treat children as young as six months old with severe atopic dermatitis

Read more ››
By: GlobenewsWire - 27 Jan 2023
Related companies:  Sanofi SA

BioSenic appoints Yves Sagot as Independent Director

Read more ››
By: GlobenewsWire - 27 Jan 2023
Related companies:  BioSenic SA

Pfizer Launches AF Journey Website To Improve Atrial Fibrillation Health Literacy

Read more ››
By: PR Newswire Association LLC. - 27 Jan 2023

ExeGi Pharma Announces Clearance of Investigational New Drug (IND) Application for EXE-346 a Live Biotherapeutic Biologic Drug

Read more ››
By: PR Newswire Association LLC. - 27 Jan 2023
Related companies:  Exegi Pharma, LLC.

European Medicines Agency accepts Marketing Authorization Application for lecanemab as treatment for early Alzheimer's disease: BioArctic

Read more ››
By: PR Newswire Association LLC. - 27 Jan 2023
Related companies:  BioArctic AB

Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer’s Disease Accepted by European Medicines Agency

Read more ››
By: GlobenewsWire - 27 Jan 2023
Related companies:  Biogen Inc.

Malaysian Society of Plastic and Reconstructive Surgery to host extensive networking and learning event for plastic surgeons and residents

Read more ››
By: PR Newswire Association LLC. - 27 Jan 2023
Related companies:  DoctorOnCall

MENTAL HEALTH APP SESH SEES 67% DECREASE IN DEPRESSION AND ANXIETY SYMPTOMS

Read more ››
By: PR Newswire Association LLC. - 27 Jan 2023

MARKETING AUTHORIZATION APPLICATION FOR LECANEMAB AS TREATMENT FOR EARLY ALZHEIMER'S DISEASE ACCEPTED BY EUROPEAN MEDICINES AGENCY

Read more ››
By: PR Newswire Association LLC. - 27 Jan 2023
Related companies:  Biogen Inc.

DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease

Read more ››
By: PR Newswire Association LLC. - 27 Jan 2023
Related companies:  DiscGenics, Inc.

Glaucoma Research Foundation Hosts 12th Annual Glaucoma 360 New Horizons Forum in San Francisco

Read more ››
By: PR Newswire Association LLC. - 27 Jan 2023
Related companies:  Glaucoma Research Foundation

Global Infertility Drugs Market Report 2022: Sector to Reach $4.8 Billion by 2028 at a 6.2% CAGR

Read more ››
By: PR Newswire Association LLC. - 27 Jan 2023
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑
{literal} {/literal}